---
title: "Standard Medical & Pharmaceuticals Ltd (511042) — Share Price, Financials & Analysis"
symbol: "511042"
company: "Standard Medical & Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/511042"
bse_code: "511042"
generated_at: "2026-10-13T11:01:39.136Z"
---

# Standard Medical & Pharmaceuticals Ltd (511042)

Canonical page: https://tapetide.com/stocks/511042

## Company

- **BSE Code:** 511042
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** smplindia.co.in

## About

Standard Medical & Pharmaceuticals Limited is engages in trading drugs and medicines of different ranges in hospitals.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | 100% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0.02 | 0.03 | 0.01 | 0 | 0 | 0.06 | 0 | 0.02 | 0 | 0.01 | 0 |
| Operating Profit | -0.01 | -0.02 | -0.03 | -0.01 | 0 | 0 | -0.06 | 0 | -0.02 | 0 | -0.01 | 0 |
| Other Income | 0.02 | 0.05 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.01 | 0.03 | -0.03 | -0.01 | 0 | 0.03 | -0.06 | 0 | -0.02 | 0 | -0.01 | 0 |
| Tax % | 0 | 0 | 0 | 0 | — | 0 | 0 | — | 0 | — | 0 | — |
| Net Profit | 0.01 | 0.03 | -0.03 | -0.01 | 0 | 0.03 | -0.06 | 0 | -0.02 | 0 | -0.01 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.14 | 0.15 | 0.16 | 0.18 | 0.15 | 0.13 | 0.13 | 0.06 | 0.03 | 0.03 |
| Operating Profit | -0.14 | -0.15 | -0.16 | -0.18 | -0.15 | -0.13 | -0.13 | -0.06 | -0.03 | -0.03 |
| Other Income | 0.03 | 0.03 | -0.11 | 0.11 | 0.04 | 0.02 | -1.36 | 0.05 | 0.03 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.12 | -0.13 | -0.28 | -0.08 | -0.12 | -0.12 | -1.49 | -0.01 | 0 | -0.03 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |
| Net Profit | -0.12 | -0.13 | -0.28 | -0.07 | -0.11 | -0.12 | -1.5 | -0.01 | 0 | -0.03 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 10.81 | 10.81 | 10.81 | 10.81 | 10.81 | 10.81 | 10.81 | 10.81 | 10.85 | 10.85 |
| Reserves | -26.18 | -26.3 | -26.43 | -26.71 | -26.78 | -26.9 | -27.02 | -28.51 | -28.52 | -28.52 |
| Borrowings | 7.37 | 7.65 | 8.3 | 17.94 | 18.06 | 18.24 | 18.54 | 17.54 | 17.49 | 17.49 |
| Other Liabilities | 10.87 | 10.69 | 10.57 | 0.79 | 0.73 | 0.64 | 0.45 | 0.17 | 0.19 | 0.19 |
| Total Liabilities | 2.87 | 2.85 | 3.25 | 2.83 | 2.82 | 2.79 | 2.78 | 0.01 | 0.01 | 0.01 |
| Fixed Assets | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 2.75 | 0 | 0 | 0 |
| Other Assets | 0.07 | 0.06 | 0.46 | 0.05 | 0.05 | 0.02 | 0.02 | 0 | 0 | 0 |
| Total Assets | 2.87 | 2.85 | 3.25 | 2.83 | 2.82 | 2.79 | 2.78 | 0.01 | 0.01 | 0.01 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.49 | -0.29 | -0.25 | -0.38 | -0.11 | -0.18 | -0.29 | -0.37 | 0.01 | 0 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.38 | 0 | 0 |
| Cash from Financing Activity | -2.49 | 0.28 | 0.65 | -0.03 | 0.11 | 0.18 | 0.29 | -1 | -0.01 | 0 |
| Net Cash Flow | 0 | -0.01 | 0.4 | -0.41 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 2.49 | -0.29 | -0.25 | -0.38 | -0.11 | -0.18 | -0.29 | -0.37 | 0.01 | 0 |
| CFO/OP | -607 | 207 | 167 | 238 | 61 | 120 | 223 | 285 | -17 | 0 |

### Ratios

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROCE % | — | — | — | — | -3.87 | -5.66 | -5.36 | -10.14 | — | — |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 |
| --- | --- | --- |
| Promoters | 5.87% | 5.87% |
| DIIs | 10.82% | 10.82% |
| Public | 83.31% | 83.31% |
| No. of Shareholders | 35149 | 35145 |

### Quarterly

| Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 5.87% | 5.87% | 5.87% | 5.87% | 5.87% | 5.87% | 5.87% | 5.87% |
| DIIs | 10.82% | 10.82% | 10.82% | 10.82% | 10.82% | 10.82% | 10.82% | 10.82% |
| Public | 83.31% | 83.31% | 83.31% | 83.31% | 83.31% | 83.31% | 83.31% | 83.31% |
| No. of Shareholders | 35151 | 35151 | 35149 | 35149 | 35149 | 35147 | 35145 | 35145 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 7 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1277.69 | Sell |
| EMA (10) | 1268.11 | Sell |
| SMA (20) | 1259.77 | Buy |
| EMA (20) | 1269.57 | Sell |
| SMA (50) | 1303.33 | Sell |
| EMA (50) | 1304.18 | Sell |
| SMA (100) | 1389.74 | Sell |
| EMA (100) | 1354.76 | Sell |
| SMA (200) | 1427.89 | Sell |
| EMA (200) | 1399.43 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.91 | Neutral |
| MACD (12,26,9) | -6.79 | Buy |
| Stochastic (14,3,3) | 42.81 | Neutral |
| ADX (14) | 11.33 | Neutral |
| Williams %R (14) | -52.71 | Neutral |
| ATR (14) | 47.04 | High Volatility |
| ROC (12) | 2.67 | Buy |
| Stoch RSI (14) | 64.63 | Neutral |
| UO (7,14,28) | 50.69 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-02-02 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1931df9b-49dc-4645-aa0d-601848ec7eb2.pdf) |
| 2026-01-31 | [Results - Financial Results For December 31 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/846f45d1-c429-4e3f-a76c-bd62cc0354ec.pdf) |
| 2026-01-31 | [Board Meeting Outcome for Outcome Of Board Meeting Held 31St January 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/364b3a81-54e3-41cb-ad02-5b5da1aed84c.pdf) |
| 2026-01-30 | [Draft Letter of Offer](https://www.bseindia.com/xml-data/corpfiling/AttachHis/331B427B-9707-4E9A-B2A0-18C1C37E99DB-132530.pdf) |
| 2026-01-28 | [Board Meeting Intimation for Board Meeting To Be Held On 31St January 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/64e82756-b085-485d-afd7-8bde39ac56c8.pdf) |
| 2018-02-14 | [Unaudited Financial Results For The Quarter Ended December 31, 2017](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba94851e-1f96-441a-be0a-559b5053abb7.pdf) |
| 2018-02-14 | [Board Meeting-Outcome of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81e9a010-c521-4aea-bd3a-680640d5c951.pdf) |
| 2018-02-14 | [Unaudited Financial Results For The Quarter Ended December 31, 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/2/ba94851e-1f96-441a-be0a-559b5053abb7.pdf) |
| 2018-02-14 | [Board Meeting-Outcome of Board Meeting](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/2/81e9a010-c521-4aea-bd3a-680640d5c951.pdf) |
| 2018-02-05 | [Notice Of Meeting Of The Board Of The Company To Be Held On 14.02.2018 & Closure Of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c2eef4f-a54e-4232-bb75-5af8d482ffdf.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:39.136Z.